An Explorative RVA of the Motor Development of Children With DCD <2y (RVA_DCD)

February 20, 2024 updated by: University Ghent

An Explorative Retrospective Video-analysis of the Motor Development of Children With Developmental Coordination Disorder Before the Age of Two

This study compares motor development in three groups of infants (controls, DCD, DCD+ASD) before the age of 2 years using retrospective video analysis of infants in home video contexts.

Study Overview

Study Type

Observational

Enrollment (Actual)

49

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ghent, Belgium, 9000
        • Ghent University
      • Vancouver, Canada
        • UBC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Community sample

Description

CONTROLS:

Inclusion Criteria:

  • Availability of video material of the child before the age of 2.
  • No indication of DCD (as measured by M-ABC-2 Pc>16 and DCD-Q)
  • No indication of ASD (as measured by SRS-2 T-score ≤60 )

Exclusion Criteria:

  • Medical diagnosis possibly influencing motor development (DCD, ASD, ADHD, CP, ect)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)

DCD GROUP:

Inclusion criteria:

  • Availability of video material of the child before the age of 2.
  • Formal diagnosis of DCD provided by multidisciplinary team in Flanders
  • Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q)

Exclusion Criteria:

  • Other medical diagnosis possibly influencing motor development (ASD, ADHD, CP, ect)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)

DCD+ASD GROUP:

Inclusion criteria:

  • Availability of video material of the child before the age of 2.
  • Formal diagnosis of DCD and ASD provided by multidisciplinary team in Flanders
  • Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q)
  • Indication of ASD (as measured by SRS-2 T-score >60 )

Exclusion Criteria:

  • Other medical diagnosis possibly influencing motor development (ADHD, CP, ect.)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Controls

This groups consists of children now aged 6-12y:

  • Without a medical diagnosis possibly influencing motor development
  • Without motor problems (M-ABC-2 and DCD-Q)
  • Without social reponsiveness problems (SRS-2)
The M-ABC-2 is a motor performance test for children aged 3 trough 16 years of age. We will use Dutch-Flemish norms.
The DCD-Q is a brief parent questionnaire designed to screen for the presence of DCD in children aged 5 trough 15 years of age. We will use Dutch norms.
The SRS-2 is a parent questionnaire designed to identify social impairments associated with ASD in children 4 trough 18 years of age. We will used Dutch norms.
Retrospective video analysis will be used to explore motor development in children with DCD, DCD+ASD and controls.
Developmental Coordination Disorder + Autism Spectrum Disorder

This groups consists of children now aged 6-12y:

  • With a multidisciplinary diagnosis of DCD
  • With motor problems (M-ABC-2 and DCD-Q)
  • With social responsiveness problems (SRS-2)
The M-ABC-2 is a motor performance test for children aged 3 trough 16 years of age. We will use Dutch-Flemish norms.
The DCD-Q is a brief parent questionnaire designed to screen for the presence of DCD in children aged 5 trough 15 years of age. We will use Dutch norms.
The SRS-2 is a parent questionnaire designed to identify social impairments associated with ASD in children 4 trough 18 years of age. We will used Dutch norms.
Retrospective video analysis will be used to explore motor development in children with DCD, DCD+ASD and controls.
Developmental Coordination Disorder

This groups consists of children now aged 6-12y:

  • With a multidisciplinary diagnosis of DCD
  • With motor problems (M-ABC-2 and DCD-Q)
The M-ABC-2 is a motor performance test for children aged 3 trough 16 years of age. We will use Dutch-Flemish norms.
The DCD-Q is a brief parent questionnaire designed to screen for the presence of DCD in children aged 5 trough 15 years of age. We will use Dutch norms.
The SRS-2 is a parent questionnaire designed to identify social impairments associated with ASD in children 4 trough 18 years of age. We will used Dutch norms.
Retrospective video analysis will be used to explore motor development in children with DCD, DCD+ASD and controls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Observable Movement Quality Scale
Time Frame: 0-2years
The OMQ is a standardized 15-item observational scale to asses the movement quality. A maximum of two 5-minute compilations are assembled per child per age-category (6-12 months, 12-18 monhts, 18-24 months)
0-2years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hilde Van Waelvelde, Dr., University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2020

Primary Completion (Actual)

July 25, 2023

Study Completion (Actual)

July 25, 2023

Study Registration Dates

First Submitted

October 11, 2019

First Submitted That Met QC Criteria

October 11, 2019

First Posted (Actual)

October 15, 2019

Study Record Updates

Last Update Posted (Actual)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Movement Assessment Battery for Children 2(M-ABC-2)

3
Subscribe